FOSTER CITY, Calif.--(BUSINESS WIRE)--Dec 23, 2022--

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conference:

J.P. Morgan Healthcare Conference on Monday, January 9, 2023 beginning at 10:30 a.m. Pacific Time

The live webcast can be accessed at the company’s investors page at investors.gilead.com. The replay will be available for at least 30 days following the presentation.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website atwww.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com:https://www.businesswire.com/news/home/20221223005006/en/

CONTACT: Jacquie Ross, Investors

Investor_relations@gilead.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: BIOTECHNOLOGY HOSPITALS PHARMACEUTICAL HEALTH

SOURCE: Gilead Sciences, Inc.

Copyright Business Wire 2022.

PUB: 12/23/2022 04:05 PM/DISC: 12/23/2022 04:05 PM

http://www.businesswire.com/news/home/20221223005006/en